The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Jul 17, 2026
Snapshot (as of Jul 17, 2026): Merck & Co., Inc. (MRK) pays a $3.36 annual dividend ($0.85 quarterly), yielding 2.62% at $128.42/share. Next ex-dividend date 2026-06-15. 21 consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 2.62%
Annual Dividend: $3.36 per share
Payout Ratio: 92.1%
Ex-Dividend Date: 2026-06-15
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 57
Merck & Co., Inc. dividend income comes from one of the largest pharmaceutical companies in the world, with operations spanning oncology, vaccines, and animal health. MRK currently pays $3.36 per share annually, distributed quarterly, with the next ex-dividend date on June 15, 2026. The current yield stands at 2.72%. With a beta of 0.205, MRK stock moves far less than the broader market, which suits income investors who prioritize low volatility over aggressive growth.
Merck & Co., Inc. pays out 92.1% of earnings as dividends, a payout ratio classified as high (above 75%). That level is supported by demand across MRK's pharmaceutical and animal health divisions, which serve drug wholesalers, hospitals, government agencies, and managed care organizations. Merck & Co., Inc. dividend safety faces pressure from that payout ratio leaving limited room to absorb earnings declines, particularly if key therapeutic areas like oncology or virology face pricing or competitive headwinds.
Merck & Co., Inc. dividend history shows a CAGR of 5.5% per year from 2011 to 2025. The per-share payment grew from $1.56 to $3.28 over that period (2026 data is partial and excluded from the growth calculation). The smallest annual increase in the window was 2.2% in 2016, while the largest reached 13.6% in 2019, showing meaningful variation in the pace of raises year to year.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +5.4% | $2.80 (2022) | $3.28 (2025) |
| 5-Year | +5.8% | $2.48 (2020) | $3.28 (2025) |
| 10-Year | +6.1% | $1.81 (2015) | $3.28 (2025) |
Merck & Co., Inc. fits dividend investors who want moderate, growing income from a large pharmaceutical business with low price volatility. The yield of 2.72% sits above MRK's own 5-year average of 2.4%, which means the current entry point offers slightly more income than the historical norm. The yield classification is moderate (2-4%), and 21 consecutive years of dividend increases adds a degree of reliability to that income. The trade-off is a 92.1% payout ratio that leaves little cushion, meaning the dividend's continuity depends heavily on sustained earnings from core segments like oncology and animal health.
| Payment Date | Amount per Share |
|---|---|
| 2026-06-15 | $0.8500 |
| 2026-03-16 | $0.8500 |
| 2025-12-15 | $0.8500 |
| 2025-09-15 | $0.8100 |
| 2025-06-16 | $0.8100 |
| 2025-03-17 | $0.8100 |
| 2024-12-16 | $0.8100 |
| 2024-09-16 | $0.7700 |
| 2024-06-17 | $0.7700 |
| 2024-03-14 | $0.7700 |
| Year | Total Dividends |
|---|---|
| 2026 | $1.7000 |
| 2025 | $3.2800 |
| 2024 | $3.1200 |
| 2023 | $2.9600 |
| 2022 | $2.8000 |
Project income from MRK with the MRK dividend calculator or track your full portfolio with the dividend tracker.